Darden (DRI): LongHorn Keeps Carrying the Portfolio While Olive Garden’s Growth Fades
Darden Restaurants (DRI) reported fiscal Q1 earnings slightly below estimates, with revenue at $3.20B and EPS at $2.05. Shares initially dropped 5% but recovered partially. LongHorn Steakhouse led growth with 6.2% comps, while Olive Garden slowed to 1.1%. Analysts remain divided, with some citing cost discipline and others noting decelerating demand. DRI reaffirmed its full-year targets. Key tickers: DRI, EAT, TXRH, CASY, QSR.
How this was made
The 30-second read
Why it matters
The earnings miss triggered a short‑term sell‑off, but management's unchanged FY2027 guidance and positive performance at LongHorn and Yard House may limit further decline.
Market read
The report provides fresh earnings data for a large‑cap restaurant chain, influencing both the stock and the broader dining sector.
What to watch
World Cup‑related traffic boost and a lettuce scare may be temporary; underlying consumer spending trends could be more decisive.
Background
Darden Restaurants (DRI) posted Q1 results that fell short of Wall Street expectations, with EPS of $2.05 vs $2.06 estimate and revenue of $3.20B vs $3.21B estimate.
Ticker impact
Darden Restaurants reported Q1 earnings that missed EPS and revenue estimates, causing a 5% share drop before partially recovering.
likely modest pressure as the market prices in the earnings shortfall
The miss on both EPS and revenue is a fresh primary disclosure for a large‑cap restaurant operator; guidance remains unchanged, so the move is expected to be limited.
Market effects
Signals a slowdown in restaurant comparable‑sales growth, potentially affecting peers like Brinker and Texas Roadhouse.
U.S. consumer discretionary sector may see slight weakness as dining traffic concerns rise.
Limited to U.S. equities; no broader macro impact.
Counterpoint
LongHorn and Yard House momentum could offset the broader slowdown, offering a buying opportunity on the dip.
Key entities
- ExecutiveRick Cardenas
CEO of Darden Restaurants, provided commentary that helped stabilize the stock.
- AnalystFreedom Capital
Maintains a Buy rating with a raised price target to $260.
